Premium Information is available for this item - Upgrade for $1 a day
6550-01-098-0263
Usp Anti-D Blood Grouping Serum
6550010980263 010980263 1226 NOVASERA
Managed by United States
NSN Created on 24 Jul 1980
Data Last Changed
January 2023
January 2023
NATO Update Count
4
4
NATO Data Quality
Marketplace 6550-01-098-0263
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6550-01-098-0263 5+ Documents (More...)
Serum 011533029 Anti-D Blood Grouping Serum 009750613 207-3687 6550-33-190-0115 00-975-0613 6550-01-098-0263
6550-01-267-9636 Anti-D Blood Grouping Serum 010980263 207-3687 6550-33-190-0115 https//www.nsnlookup.com
Usp Anti-D Blood Grouping Serum 010980263 207-3687 6550-33-190-0115 https//www.nsnlookup.com /fsg
6550-01-267-9636 Anti-D Blood Grouping Serum 010980263 207-3687 6550-33-190-0115 https//www.nsnlookup.com
Usp Anti-D Blood Grouping Serum 010980263 207-3687 6550-33-190-0115 https//www.nsnlookup.com /fsg
-190-0115 NATO Stock Numbers Related to 6550-00-975-0613 6550-01-057-2575 6550-33-207-3687 Serum 010980263
Usp Anti-D Blood Grouping Serum 001598575 159-8575 6550-01-057-2575 6550-33-207-3687 6550/us 6550-01-098-0263
Usp Anti-D Blood Grouping Serum 010980263 098-0263 6550-01-057-2575 6550-33-207-3687 https//www.nsnlookup.com
Usp Anti-D Blood Grouping Serum 001598575 159-8575 6550-01-057-2575 6550-33-207-3687 6550/us 6550-01-098-0263
Usp Anti-D Blood Grouping Serum 010980263 098-0263 6550-01-057-2575 6550-33-207-3687 https//www.nsnlookup.com
6550-01-267-9636 Anti-D Blood Grouping Serum 010980263 207-3687 6550-33-190-0115 6550-00-975-0613
6550-01-098-0263 6550-01-267-9636 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-00-975-0613 Usp
6550-01-267-9636 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-098-0263 Usp Anti-D Blood
6550-01-098-0263 6550-01-267-9636 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-00-975-0613 Usp
6550-01-267-9636 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-098-0263 Usp Anti-D Blood
975-0613 Usp Anti-D Blood Grouping Serum 009750613 207-3687 6550-33-190-0115 6550-00-975-0613 6550-01-098-0263
159-8575 Usp Anti-D Blood Grouping Serum 001598575 207-3687 6550-33-190-0115 6550-00-975-0613 6550-01-098-0263
6550-01-267-9636 6550-00-159-8575 6550-01-153-3029 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-098-0263
159-8575 Usp Anti-D Blood Grouping Serum 001598575 207-3687 6550-33-190-0115 6550-00-975-0613 6550-01-098-0263
6550-01-267-9636 6550-00-159-8575 6550-01-153-3029 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-098-0263
6550-01-313-4812 6550-01-359-5096 6550-01-230-8734 https//www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-098-0263
Usp Anti-D Blood Grouping Serum 010980263 098-0263 6550-01-267-9636 6550-00-159-8575 6550-01-153
Related to 6550-01-230-8734 6550-01-057-2575 6550-33-207-3687 6550-33-190-0115 6550-00-975-0613 6550-01-098-0263
Usp Anti-D Blood Grouping Serum 010980263 098-0263 6550-01-267-9636 6550-00-159-8575 6550-01-153
Related to 6550-01-230-8734 6550-01-057-2575 6550-33-207-3687 6550-33-190-0115 6550-00-975-0613 6550-01-098-0263
Restrictions 6550-01-098-0263
6550-01-098-0263 is a Usp Anti-D Blood Grouping Serum that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6550-01-098-0263
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6550-01-098-0263
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6550-01-098-0263
- Part Number
- Manufacturer
- Status
- 1226
- Manufacturer
- 04507 - Ortho Pharmaceutical Corp (Obsolete)
- Primary Buy
- Primary Buy
- NOVASERA
- 04507 - Ortho Pharmaceutical Corp (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6550-01-098-0263
- Characteristic
- Specifications
- FIIG
- Specifications
- A10000
- Physical Form [AGXW]
- Liquid
- Primary Container Type [CQCT]
- Bottle, Dropper
- Primary Container Content Quantity [CRLK]
- 10.000 Milliliters
NATO Stock Numbers Related to 6550-01-098-0263
Freight Information 6550-01-098-0263
6550-01-098-0263 has freight characteristics.. 6550-01-098-0263 has a variance between NMFC and UFC when transported by rail and the description should be consulted.
Packaging Data 6550-01-098-0263
- Responsible Activity
- Packaging Data Source
- Primary Inventory Control Activity (PICA)
- Packaging Data does not meet current MIL-STD-2073-1E
Item Pack Level (Unpackaged)
- Item Size
- Item Weight
- Characteristics
- Weight/Dimensions Category
- Fragility
- Item Preservation
- Item Weight
- --
- --
- --
- --
- --
- --
Unit Pack Level (Packaged)
- Quantity per Pack
- Unit Size
- Unit Weight
- Unit Cube
- Preservation Method
- Cleaning/Drying
- Unit Size
- --
- --
- --
- --
- --
- Special Requirements
- --
- Preservation Material
- Wrapping Material
- Cushioning/Dunnage
- Cushioning Thickness
- Container
- Special Marking
- Wrapping Material
- Special Requirement
- Special Requirements – see Specific Instructions or Drawings provided
- Special Requirements. See Specific Instructions or Drawings Provided
- Special Requirements. See Specific Instructions or Drawings Provided
- Special requirement – See specific instructions or drawings provided
- --
- Special Requirements – see Specific Instructions or Drawings provided
Intermediate Pack Level
- Quantity of Unit Packs
- Container
- Special requirement – See specific instructions or drawings provided